The State of Our HLTH 2019

Press

The State of Our HLTH 2019

At last year’s HLTH conference, RxRevu was invited to the stage to discuss drug price transparency and our hopes for the future.  As part of the Drug Price Transparency Debates, Carm Huntress discussed how industry stakeholders can make an impact on patient pricing, and why it is important to collaborate across the industry.

Read the full report here.

Related content